Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumors have more favorable outcomes than true local disease recurrences

Cancer

Volumn 95, Issue 10, 2002, Pages 2059-2067

  Huang, Eugene ^a   Buchholz, Thomas A ^a   Meric, Funda ^a   Krishnamurthy, Savitri ^a   Mirza, Nadeem Q ^a   Ames, Frederick C ^a   Feig, Barry W ^a   Kuerer, Henry M ^a   Ross, Merrick I ^a   Singletary, S Eva ^a   McNeese, Marsha D ^a   Strom, Eric A ^a   Hunt, Kelly K ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast conservation therapy; Histology; Local disease recurrence; New primary tumor

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; FEMALE; HISTOLOGY; HORMONAL THERAPY; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY;

ACTUARIAL ANALYSIS; ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 0037110702     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10952     Document Type: Article

References (26)

1. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet. 1991;338:327-331.
2. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy: Frequency, time course, and prognosis. Cancer. 1989;63:1912-1917.
3. Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990;19:833-842.
4. Haffty BG, Fischer D, Beinfield M, McKhann C. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991;21:293-298.
5. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst. 1995;87:19-27.
6. Whelan T, Clark R, Roberts R, Levine M, Foster G. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. Int J Radiat Oncol Biol Phys. 1994;30:11-16.
7. Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1990;43:25-38.
8. Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1990;18:87-93.
9. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys. 1989;17:719-725.
10. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C. Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996;14:52-57.
11. Kurtz JM, Spitalier JM, Amalric R. Late breast recurrence after lumpectomy and irradiation. Int J Radiat Oncol Biol Phys. 1983;9:1191-1194.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
13. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 1977;35:1-39.
14. Gage I, Schnitt SJ, Recht A, et al. Skin recurrences after breast-conserving surgery for early-stage breast cancer. J Clin Oncol. 1998;16:480-486.
15. Fisher B, Redmond C, Poisson R, et al. Eight year results of randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822-828.
16. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907-911.
17. Shattuck-Eidens D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA. 1997;278:1242-1250.
18. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997;336:1409-1415.
19. Fitzgerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. N Engl J Med. 1996;334:143-149.
20. Chabner E, Nixon A, Gelman R, et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1998;16:2045-2051.
21. Newman LA, Sahin AA, Bondy ML, et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer. 2001;91:1845-1853.
22. Dalberg D, Johansson H, Johansson U, Rutqvist LE. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Stockholm Breast Cancer Study Group. Cancer. 1998;82:2204-2211.
23. Fisher B, Dignam J, Bryant J, et al. Five versus more that five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 1996;88:1529-1542.
24. Fisher B, Costantino JP, Wickerham L, et al. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90:1371-1383.
25. Buchholz TA, Tucker SL, Erwin J, et al. Impact of systemic treatment on local control for patients with lymph nodenegative breast cancer treated with breast-conserving therapy. J Clin Oncol. 2001;19:2240-2246.
26. Smith TE, Daesung L, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognosis, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48:1281-1289.